Contact sensitivity in alloxan-diabetic mice

Area of Science:

• Immunology
• Endocrinology
• Diabetology

Background:

• Alloxan-induced diabetes in mice is a model for studying metabolic and immune system interactions.
• Diabetes mellitus is known to affect various immune functions, but the specific impact on T-cell mediated responses requires further elucidation.

Purpose of the Study:

• To investigate the effect of alloxan-induced diabetes on contact sensitivity in mice.
• To determine the role of insulin in modulating immune responses in diabetic mice.
• To assess the function of T lymphocytes in the context of diabetes.

Main Methods:

• Induction of diabetes in Swiss, CBA, and DBA/2 mice using alloxan.
• Assessment of contact sensitivity to oxazolone in diabetic and normoglycaemic control mice.
• Evaluation of thymus and spleen weights.
• Administration of insulin to diabetic mice and assessment of immune parameters.
• Passive transfer experiments using sensitized lymphocytes from diabetic and control mice.

Main Results:

• Alloxan-diabetic mice exhibited significantly reduced contact sensitivity to oxazolone compared to controls.
• Diabetic mice showed involution of the thymus and spleen.
• Insulin treatment partially restored contact sensitivity and increased lymphatic organ weights in diabetic mice.
• Non-specific inflammatory responses were not impaired in insulin-deficient mice.
• Passive transfer of sensitized lymphocytes failed to transfer contact sensitivity, indicating an intrinsic defect.

Conclusions:

• Alloxan-induced diabetes in mice leads to a depression of T-lymphocyte mediated contact sensitivity.
• Insulin therapy can partially ameliorate this immune dysfunction.
• The findings suggest that T-lymphocyte function is impaired in alloxan-diabetic mice.